Mallinckrodt Plc
(NYSE : MNK)

( )
MNK After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
CTLTCatalent, Inc. -3.70%80.802.1%$222.46m
SAVACassava Sciences, Inc. -0.51%9.710.0%$169.20m
JAZZJazz Pharmaceuticals Plc -0.01%138.052.4%$166.39m
HZNPHorizon Therapeutics Plc -5.58%75.335.8%$155.15m
MRNSMarinus Pharmaceuticals, Inc. -10.91%10.707.8%$120.06m
CORTCorcept Therapeutics, Inc. -1.67%16.785.5%$117.65m
VRXValeant Pharmaceuticals International, Inc. -3.24%15.2314.1%$89.62m
BHCBausch Health Cos., Inc. -3.24%15.230.0%$60.32m
MYOKMyoKardia, Inc. 0.49%130.021.8%$58.56m
ARGXargenx SE -1.13%243.070.0%$54.10m
AMRNAmarin Corp. Plc -1.09%3.641.5%$53.67m
SAGESAGE Therapeutics, Inc. -1.83%58.908.6%$45.38m
GWPHGW Pharmaceuticals Plc -1.50%98.506.2%$41.18m
AXSMAxsome Therapeutics, Inc. -2.14%75.931.9%$38.49m
PRGOPerrigo Co. Plc -0.90%44.966.8%$36.50m

Company Profile

Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Blanchardstown, Dublin.